Dataset Open Access

Large-scale purification of Q23 and Q54 HTT from Sf9 and EXPI293F expression systems 2019/07/22

Harding, Rachel; Hutchinson, Ashley; Seitova, Alma; Arrowsmith, Cheryl; Edwards, Aled


BibTeX Export

@dataset{harding_rachel_2019_3383250,
  author       = {Harding, Rachel and
                  Hutchinson, Ashley and
                  Seitova, Alma and
                  Arrowsmith, Cheryl and
                  Edwards, Aled},
  title        = {{Large-scale purification of Q23 and Q54 HTT from 
                   Sf9 and EXPI293F expression systems 2019/07/22}},
  month        = jul,
  year         = 2019,
  note         = {{Dr. Harding is the recipient of the Huntington's 
                   Disease Society of America Berman Topper Career
                   Development Fellowship which funds and supports
                   this research, in addition to generous funding
                   from the CHDI Foundation and the Huntington
                   Society of Canada. The SGC is a registered charity
                   (number 1097737) that receives funds from AbbVie,
                   Bayer Pharma AG, Boehringer Ingelheim, Canada
                   Foundation for Innovation, Eshelman Institute for
                   Innovation, Genome Canada through Ontario Genomics
                   Institute [OGI-055], Innovative Medicines
                   Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766],
                   Janssen, Merck KGaA, Darmstadt, Germany, MSD,
                   Novartis Pharma AG, Ontario Ministry of Research,
                   Innovation and Science (MRIS), Pfizer, São Paulo
                   Research Foundation-FAPESP, Takeda, and Wellcome.}},
  publisher    = {Zenodo},
  doi          = {10.5281/zenodo.3383250},
  url          = {https://doi.org/10.5281/zenodo.3383250}
}
63
47
views
downloads
All versions This version
Views 6363
Downloads 4747
Data volume 22.4 MB22.4 MB
Unique views 5656
Unique downloads 3434

Share

Cite as